Myovant Sciences Profit Margin 2017-2022 | MYOV
Current and historical gross margin, operating margin and net profit margin for Myovant Sciences (MYOV) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Myovant Sciences net profit margin as of December 31, 2022 is -48.47%.
| Myovant Sciences Annual Profit Margins |
| Myovant Sciences Quarterly Profit Margins |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$2.613B |
$0.231B |
|
Myovant Sciences Ltd. is a biopharmaceutical company. It focused on developing and commercializing therapies for women's health diseases and other endocrine-related disorders, including advanced prostate cancer. The company's product candidate consists of relugolix which are in clinical trial, an oral once-daily small molecule that acts as a gonadotropin-releasing hormone receptor antagonist. Myovant Sciences Ltd. is based in Hamilton, Bermuda.
|
